T
Protara Therapeutics D
D
TARA
3.06000
USD
0.08
(2.68%)
مغلق
حجم التداول
19,536
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
118,060,501
العنوان: Protara Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failureassociated liver disease (IFALD).